Stay updated on Pembrolizumab CNS Metastases Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab CNS Metastases Clinical Trial page.

Latest updates to the Pembrolizumab CNS Metastases Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.5.4 replaces the previous v3.5.3 on the study page. This represents a minor site build update to the rendering template used for the record, with no change to the study data.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check33 days agoChange DetectedSystem revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check62 days agoChange DetectedVersion update from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check70 days agoChange DetectedResults Submitted appears, replacing No Results Posted. The page revision has been updated to v3.4.3 from v3.4.2.SummaryDifference0.1%

- Check98 days agoChange DetectedAddition: Revision: v3.4.2. Deletions: removal of a government funding lapse notice and related operating-status updates (Revision: v3.4.1).SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab CNS Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab CNS Metastases Clinical Trial page.